The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease

Figure 1

Plasma sRAGE and S100A12 levels in different groups. (a) Plasma levels of sRAGE in four groups. (b) Plasma levels of sRAGE in four groups with or without DM. (c) Plasma levels of S100A12 in four groups. (d) Plasma levels of S100A12 in four groups with or without DM.

(a)

(b)

(c)

(d)